A systematic review of scope and quality of health economic evaluation studies in vietnam

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Tran, Bach Xuan ^a,b   Nong, Vuong Minh ^b   Maher, Rachel Marie ^b   Nguyen, Phuong Khanh ^c   Luu, Hoat Ngoc ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b HANOI MEDICAL UNIVERSITY   (Viet Nam)

^c MINISTRY OF HEALTH   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

COST; COST BENEFIT ANALYSIS; FACTUAL DATABASE; HEALTH ECONOMICS; HUMAN; MANAGEMENT; VIET NAM;

COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DATABASES, FACTUAL; ECONOMICS, MEDICAL; HUMANS; POLICY MAKING; VIETNAM;

EID: 84905996423     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103825     Document Type: Review

References (38)

1. Lindholm L, Thanh NX (2003) The role of health economics in Vietnam: a tentative research agenda. Scand J Public Health Suppl 62: 66-69.
2. Young J (2005) Research, policy and practice: why developing countries are different. Journal of International Development 17: 727-734.
3. Peterson LE, Goodman C, Karnes EK, Chen CJ, Schwartz JA (2009) Assessment of the quality of cost analysis literature in physical therapy. Phys Ther 89: 733-755.
4. Ofman JJ, Sullivan SD, Neumann PJ, Chiou CF, Henning JM, et al. (2003) Examining the value and quality of health economic analyses: implications of utilizing the QHES. J Manag Care Pharm 9: 53-61.
5. Acharya A, Adam T, Baltussen R, Evans D, Hutubessy R, et al. (2003) Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis.
6. Tantivess S (2008) Policy making and roles of health technology assessment. J Med Assoc Thai 91 Suppl 2: S88-99.
7. Desai PR, Chandwani HS, Rascati KL (2012) Assessing the quality of pharmacoeconomic studies in India: a systematic review. Pharmacoeconomics 30: 749-762.
8. Gavaza P, Rascati KL, Oladapo AO, Khoza S (2010) The state of health economic evaluation research in Nigeria: a systematic review. Pharmacoeconomics 28: 539-553.
9. Gavaza P, Rascati KL, Oladapo AO, Khoza S (2012) The state of health economic research in South Africa: a systematic review. Pharmacoeconomics 30: 925-940.
10. Morel CM, Thang ND, Erhart A, Xa NX, Peeters Grietens K, et al. (2013) Cost-effectiveness of long lasting insecticide-treated hammocks in preventing malaria in South-central Vietnam. PLoS One8: e58205.
11. Casey GJ, Sartori D, Horton SE, Phuc TQ, Phu LB, et al. (2011) Weekly ironfolic acid supple mentation with regular deworming is cost-effective in preventing anaemia in women of reproductive age in Vietnam. PLoS One 6: e23723.
12. Tsu VD, Levin C, Tran MP, Hoang MV, Luu HT (2009) Cost-effectiveness analysis of active management of third-stage labour in Vietnam. Health Policy Plan 24: 438-444.
13. Tran BX, Ohinmaa A, Duong AT, Nguyen LT, Vu PX, et al. (2012) The cost-effectiveness and budget impact of Vietnam's methadone maintenance treatment programme in HIV prevention and treatment among injection drug users. Global Public Health 7: 1080-1094.
14. Kim JJ, Kobus KE, Diaz M, O'Shea M, Van Minh H, et al. (2008) Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policy. Vaccine 26: 4015-4024.
15. Vuong DA, Rades D, Le AN, Busse R (2012) The cost-effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of brain metastasis in Vietnam from the perspective of patients and families. World Neurosurg 77: 321-328.
16. Love RR, Duc NB, Allred DC, Binh NC, Dinh NV, et al. (2002) Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer. J Clin Oncol 20: 2559-2566. (Pubitemid 34525744)
17. Suba EJ, Nguyen CH, Nguyen BD, Raab SS (2001) De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam. Cancer 91: 928-939.
18. Tran BX, Ohinmaa A, Duong AT, Nguyen LT, Vu PX, et al. (2012) Cost-effectiveness of integrating methadone maintenance and antiretroviral treatment for HIV-positive drug users in Vietnam's injection-driven HIV epidemics. Drug Alcohol Depend 125: 260-266.
19. Higashi H, Barendregt JJ (2012) Cost-effectiveness of tobacco control policies in Vietnam: the case of personal smoking cessation support. Addiction 107: 658-670.
20. Ha DA, Chisholm D (2011) Cost-effectiveness analysis of interventions to prevent cardiovascular disease in Vietnam. Health Policy Plan 26: 210-222.
21. Kim SY, Goldie SJ, Salomon JA (2009) Cost-effectiveness of Rotavirus vaccination in Vietnam. BMC Public Health 9: 29.
22. Cook J, Jeuland M, Whittington D, Poulos C, Clemens J, et al. (2008) The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries. Vaccine 26: 6305-6316.
23. Fischer TK, Anh DD, Antil L, Cat ND, Kilgore PE, et al. (2005) Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. J Infect Dis 192: 1720-1726. (Pubitemid 41587821)
24. Danielsson N, Hoa DP, Thang NV, Vos T, Loughnan PM (2004) Intracranial haemorrhage due to late onset vitamin K deficiency bleeding in Hanoi province, Vietnam. Arch Dis Child Fetal Neonatal Ed 89: F546-550. (Pubitemid 39472329)
25. Holmes CB, Coggin W, Jamieson D, Mihm H, Granich R, et al. (2010) Use of generic antiretroviral agents and cost savings in PEPFAR treatment programs. JAMA 304: 313-320.
26. Tran BX, Ohinmaa A, Duong AT, Do NT, Nguyen LT, et al. (2012) Costeffectiveness of methadone maintenance treatment for HIV-positive drug users in Vietnam. AIDS Care 24: 283-290.
27. Higashi H, Truong KD, Barendregt JJ, Nguyen PK, Vuong ML, et al. (2011) Cost effectiveness of tobacco control policies in Vietnam: the case of populationlevel interventions. Appl Health Econ Health Policy 9: 183-196.
28. Huong NT, Chongsuvivatwong V, Geater A, Prateepchaikul L (2001) Costbenefit analysis of urine pregnancy tests prior to menstrual regulation in Vietnam. Am J Public Health 91: 825-826. (Pubitemid 32397927)
29. Yn NT, Kien VD, Anh NPL (2006) Chi phi-hiu qu ca tiem vacxin Crossed d sign kim soat bnh viem nao Nht Bn ti Vit Nam. Y hc d phong XVI-1: 32-36.
30. Ha NT, Anh NQ, Linh BN, Hng NT (2012) Phan tich chi phi-hiu qu ca cac can thip Crossed d signiu tr bnh tam thn phan lit ti Vit Nam. Y hc d phong XXII-2: 54-59.
31. Th LT, Nga CN (2003) Phan tich chi phi, hiu qu trong chng nga viem gan sieu vi B nhom tui 10-14 tui khi s dng phac Crossed d sign 2 liu vaccin. Y hc thc hanh 11: 38-41.
32. Kien VD, Minh HV (2012) Chi phi hiu qu ca chng trinh 100% bao cao su nhm phong chng lay truyn HIV cho nhom gai mai dam ti tnh An Giang. Tp chi nghien cu khoa hc 79: 127-131.
33. Nga CN, Th LT (2003) Phan tich chi phi, hiu qu hai phng phap sang lc va khong sang lc trong chng nga viem gan sieu vi B Y hc thc hanh 8: 62-66.
34. Sn NCrossed D sign (2008) Nghien cu chi phi-hiu qu chng trinh tiêm chng m rng ti huyn Crossed d signng bngPhu Lc va huyn min nui Nam Crossed D signong ti tnh Tha Thien Hu nǎm 2008. Y hc d phong XIX - 2: 116-122.
35. Thatte U, Hussain S, de Rosas-Valera M, Malik MA (2009) Evidence-Based Decision on Medical Technologies in Asia Pacific: Experiences from India, Malaysia, Philippines, and Pakistan. Value in Health 12 Suppl 3: S18-S25.
36. Jirawattanapisal T, Kingkaew P, Lee TJ, Yang MC (2009) Evidence-Based Decision-Making in Asia-Pacific with Rapidly Changing Health-Care Systems: Thailand, South Korea, and Taiwan. Value in Health 12 Suppl 3: S4-S11.
37. Sivalal S (2009) Health technology assessment in the Asia Pacific region. Intl J of Tech Assessment in Health Care 25 Suppl: 196-201.
38. Tyrrell A, Worrall E, Que TN, Bates I (2011) Cost and effectiveness comparison of two methods for screening potential blood donors for anaemia in Vietnam. Transfus Med, 2011. 21(3): p. 158-65.